Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy

Journal of Infectious Diseases

Volumn 181, Issue 1, 2000, Pages 141-147

  Smith, Kimberly Y ^a   Valdez, H ^b   Landay, A ^a   Spritzler, J ^c   Kessler, H A ^a   Connick, E ^d   Kuritzkes, D ^d   Gross, B ^e   Francis, I ^e   McCune, J M ^f   Lederman, M M ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c HARVARD UNIVERSITY   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; RITONAVIR; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; PRIORITY JOURNAL; T LYMPHOCYTE; THYMUS; VIRUS LOAD; VIRUS REPLICATION;

ADULT; AGED; ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LAMIVUDINE; LYMPHOCYTES; MALE; MIDDLE AGED; RITONAVIR; T-LYMPHOCYTE SUBSETS; THYMUS GLAND; TOMOGRAPHY; ZIDOVUDINE;

EID: 0033958888     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315169     Document Type: Article

References (19)

1. 1. Lederman M, Connick E, Landay A, et al. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS clinical trials groups protocol 315. J Infect Dis 1998;178:70-8.
2. + T-cell homeostasis and function in advanced HIV disease. Science 1997;277:112-6.
3. 3. Steinmann GG. Changes in the human thymus during aging. In: Muller-Hermelink HK, ed. The human thymus: histopathology and pathology. Vol. 75. New York: Springer-Verlag, 1986:43-88.
4. 4. Hakim F, Capeda R, Kaimei S, et al. Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 1997;90:3789-98.
5. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995;332:143-7.
6. + T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997;98:3700-07.
7. 7. Bonyhadi ML, Rabin L, Salimi S, et al. HIV induces thymus depletion in vivo. Nature. 1993;363:728-32.
8. 8. McCune JM, Loftus R, Schmidt DK, et al. High prevalence of thymic tissue in adults with HIV infection. J Clin Invest 1998;101:2301-8.
9. 9. Connick E, Lederman M, Kotzin B, et al. Immunologic effects of 48 weeks of AZT/3TC/ritonavir [abstract LB14]. 5th Conference on Retroviruses and Opportunistic Infections (Chicago, IL) 1-5 February, 1998.
10. 10. Badley AD, Dockrell DH, Algeciras A, et al. In vivo analysis of FAS/FasL interactions in HIV infected patients. J Clin Invest 1998;102:79-87.
11. 11. Leeanderson AC, Bratt G, Hinkula J, et al. Induction of specific T-cell responses in HIV infection. AIDS 1998;12:157-66.
12. 12. Hellerstein M, Hanley MB, Cesar D, et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1 infected humans. Nat Med 1999;6:83-9
13. 13. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998;396: 690-4.
14. 14. Volberding PA, Deeks SG. Antiretroviral therapy for HIV infection: promises and problems. JAMA 1998;279:1343-4.
15. 15. Hoetelmans RM, Meenhorst PL, Mulder JW, et al. Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir and ritonavir. Pharm World Sci 1997;19:159-75.
16. 16. Valdez H, Lederman MM. Cytokines and cytokine therapies in HIV infection. AIDS Clin Rev 1997-98;187-228.
17. 17. Havlir DV, Marschner IC, Hirsch MS, et al. Maintenance antiretroviral therapies in HIV infected subjects with undetectable plasma HIV RNA after triple drug therapy. N Engl J Med 1998;339:1261-76.
18. 18. De Boer RJ, Perelson AS. Target cell limited and immune control models of HIV infection: a comparison. J Theor Biol 1998;190:201-14.
19. 19. Vigano A, Vella S, Principi N, et al. Thymus imaging in the evaluation of T-cell destruction and reconstitution in vertical HIV infection [abstract 267]. Program, 5th Conference on Retroviruses and Opportunistic Infections (Chicago, IL). 1-5 February, 1998.